What marijuana reclassification could mean for medical research

The U.S. pot sector could see an influx of medical research funding from healthcare investors amid renewed interest from pharmaceutical firms, should a proposal to reclassify cannabis as a lower-risk substance be approved, industry experts said.

Continue reading.

Image by jcomp on Freepik

Source: